Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Pulse Biosciences Inc

PLSE
Current price
16.89 USD +0.33 USD (+1.99%)
Last closed 16.86 USD
ISIN US74587B1017
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange NASDAQ
Capitalization 1 134 238 080 USD
Yield for 12 month +26.80 %
1Y
3Y
5Y
10Y
15Y
PLSE
21.11.2021 - 28.11.2021

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; CellFX nsPFA Percutaneous Electrode system for soft tissue ablation in surgical setting; CellFX nsPFA Cardiac Clamp designed for use in surgical treatment of atrial fibrillation (AF); CellFX nsPFA 360° Cardiac Catheter designed to provide a circumferential, or circular, ablation in a single treatment cycle; and The CellFX Consol, a tunable, software-enabled, and console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida. Address: 601 Brickell Key Drive, Miami, FL, United States, 33131

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

5.00 USD

P/E ratio

Dividend Yield

Current Year

Last Year

-9 000 USD

Current Quarter

+832 000 USD

Last Quarter

Current Year

Last Year

-1 207 000 USD

Current Quarter

Last Quarter

Key Figures PLSE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -62 524 000 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -43.61 %
PEG Ratio
Return On Equity TTM -77.86 %
Wall Street Target Price 5.00 USD
Revenue TTM -9 000 USD
Book Value 1.76 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM -550 000 USD
Earnings per share -0.99 USD
Diluted Eps TTM -0.99 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics PLSE

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History PLSE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor
Payout Ratio TTM
Last Split Date

Stock Valuation PLSE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 64.63
Price Sales TTM 60.23
Enterprise Value EBITDA -1.81
Price Book MRQ 9.58

Financials PLSE

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators PLSE

For 52 weeks

9.70 USD 25.00 USD
50 Day MA 16.64 USD
Shares Short Prior Month 2 354 531
200 Day MA 17.85 USD
Short Ratio 12.27
Shares Short 2 383 118
Short Percent 15.41 %